News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MOSS Institute Co., Ltd. And AnGes MG Inc. Tie Up In Genomic Drug Development



10/19/2005 5:09:34 PM

MOSS Institute and AnGes MG (TSE: 4563) have announced that the two companies have reached a basic agreement on development of a new critical trial system for genomic drug development.

Read at JCN Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES